Acessibilidade / Reportar erro

Efficacy of a New Formulation of Bacillus sphaericus 2362 against Culex quinquefasciatus (Diptera: Culicidae) in Montes Claros, Minas Gerais, Brazil

Bacillus sphaericus; Culex quinquefasciatus; new formulation; mosquito control

RESEARCH NOTE

Efficacy of a New Formulation of Bacillus sphaericus 2362 against Culex quinquefasciatus (Diptera: Culicidae) in Montes Claros, Minas Gerais, Brazil

Vol. 92 (4): 571-573

Rotraut AGB Consoli, Bernadete de S Santos, Marlúcia A Lamounier, Nágila FC Secundino, Leon Rabinovitch*/ + , Cláudia MB Silva*, Regina SA Alves*, Nídia FF Carneiro**

Centro de Pesquisas René Rachou-FIOCRUZ, Av. Augusto de Lima 1715, 30190-002 Belo Horizonte, MG, Brasil *Laboratório de Fisiologia Bacteriana, Departamento de Bacteriologia, Instituto Oswaldo Cruz, Av. Brasil 4365, 21045-900 Rio de Janeiro, RJ, Brasil **Centro de Controle de Zoonoses, Prefeitura Municipal de Montes Claros, Montes Claros, MG, Brasil

Key words: Bacillus sphaericus - Culex quinquefasciatus - new formulation - mosquito control

RESEARCH NOTE

Culex quinquefasciatus Say 1823 is one of the most frequent urban and anthropofilic mosquitoes in Brazil, that besides causing intense nuisance also transmits bancroftian filariasis in some states of the country (R Consoli & R Lourenço de Oliveira 1994 Principais mosquitos de importância sanitária no Brasil, Ed. FIOCRUZ , Rio de Janeiro, 225 pp.). The concerns about growing vector resistance, the long term detrimental effects of usual chemical insecticides on non target organisms, as well as environmental polution have led to the search for safer and more target specific alternatives. Among these, Bacillus sphaericus has been considered the most important, specially in relation to Cx. quinquefasciatus control (J Weiser 1991 Biological control of vectors, UNDP/World Bank/TDR , 189 pp.). Owning to an agreement between Fundação Oswaldo Cruz (FIOCRUZ) and INPAL SA Indústrias Químicas a new production and formulation process has been developed using B. sphaericus 2362, serotype H-5a5b, that is being presently patented. This product, an emulsified concentrate, now being produced experimentally on a pre-industrial scale, presented in laboratory conditions a mean LC 50 of 1.3 ± 0.6 mg/l and LC 90 of 5.5±1.5 mg/l (dry weight basis) for L 3 /L4 Cx. quinquefasciatus larvae after 48 hr (L Rabinovitch et al. 1996 2nd En Gedi Conference on Bact Cont Agri Insect Pests Vectors Human Dis , Shoresh, Israel, Abst. 42, R Consoli et al. 1996 V SICONBIOL, Foz do Iguaçu, Brazil, Abst. 7).

The city of Montes Claros, State of Minas Gerais (16°43¢S, 43°51¢W) was selected for field trials: presenting an all year hot climate, poor sewage destination in several areas but nevertheless a motivated municipality staff eager to control the mosquito pest represented by Cx. quinquefasciatus, oriented our choice. Tests took place at a highly sewage poluted urban streamlet, named" Córrego do Carrapato" measuring 1.9 km in extension. Six experimental sections, measuring 250, 250, 300, 300, 250, 250 and 300 m, delimitated by seven collecting points and an initial control area of 100 m were established. The control section presented relatively straight margins and quick flow, both of these features reducing gradually; point 1 is near a small fall (60 cm) and has a stony botton; point 2 is also stony; point 3 is sandy and relatively deep (20/100 cm); point 4, also sandy but 5/20 cm in depth only; point 5, even shallower (5/20 cm) is placed at a broad curve; point 6 is broad, sandy and only about 5 cm deep; the same as point 7 which depth reaches 20 cm. Experiments took place during 46 days, ambiental temperature ranging between 35.8 o C and 13.2°C, very little rain occurring in this period. Treatments using the emulsified concentrate were made on days 1 (0.06 g/m 2 ), 10, 17, 37 and 44 (0.12 g/m 2 ) on all experimental points except on day 44 when only points 1 to 5 were treated. Each one consisting of four daytime knapsack sprayer treatments with 3 hr intervals covering both margins and preceded by a larval survey, by means of 5 dips (about 150 ml) made at both margins of each point. Table and Fig. present the results. In all cases only Cx. quinquefasciatus larvae were found. On day 0 a preliminary survey was made. On day 3 larvae were collected: while in the control section larvae had increased 90.5%, experimental points showed a decrease between 70.6% (3) and 97.9% (7). On day 9, in relation to 3, larvae had added too largely in control, at points 2 and 3 first and second stage larvae prevailed but appeared in small number or were absent at the remaining ones. On day 10 a second treatment took place, this time of 0.12 g/m 2 , owning to the intensive polution and large adult population present. This time due to the absence of rain, the extension of margins in section 1 increased 430 m. Day 16 presented a decrease of 5.7% larvae in control, but at points 2, 3 and 5 the reduction was 81%, 74.8% and 80% respectively and no larvae were found at other locations except at point 4 that showed a small increase. From day 24 to 30 larvae declined a few percent in control, but augmented thereafter ceaselessly. At point 1, near the control area, after declining to zero at day 30, a low mean persisted to the end; points 2 and 4 showed a constant decrease, but point 3 remained with higher means, perhaps related to the larger depth there. Larvae were completely absent from points 5 to 7, except for a few on day 46 at point 5. Attention must be also paid to the fact that other breeding places, not yet treated were not far and certainly in the flying range of ovigerous mosquito females. Longer and more complete experiments, including comparisons with other products, are planned. Present preliminary data seems to compare favourably with other control experiments of this mosquito species employing other B. sphaericus formulations (A Kumar et al. 1996 J Mosq Control Ass 12 : 409-413, R Bhalwar et al. 1993 Med J Armed Forces India 49 : 57-60, M Hougard et al. 1993 Bull WHO 71 : 367-375).


+ Corresponding author. Fax: +55-21-270.6565

Received 11 November 1996

Accepted 14 March 1997

Publication Dates

  • Publication in this collection
    14 Oct 1998
  • Date of issue
    July 1997

History

  • Accepted
    14 Mar 1997
  • Received
    11 Nov 1996
Instituto Oswaldo Cruz, Ministério da Saúde Av. Brasil, 4365 - Pavilhão Mourisco, Manguinhos, 21040-900 Rio de Janeiro RJ Brazil, Tel.: (55 21) 2562-1222, Fax: (55 21) 2562 1220 - Rio de Janeiro - RJ - Brazil
E-mail: memorias@fiocruz.br